DIRS.INFO The most relevant business & tech news

☆ Three global stocks stocks to own in 2025, according to Barclays
▼ + stars: | 2024-11-20 | by ( Amala Balakrishner | In Amala-Balakrishner | ) www.cnbc.com time to read: +3 min

The outlook for equity markets looks "decent" going into 2025, according to Barclays, as central banks cut interest rates and the global economy remains resilient. The bank named "overweight-rated stocks in which our analysts have high conviction in 2025 and see value in owning on an individual basis." Here are three of Barclays' top picks, which it gives over 35% upside potential: Shell Barclays is bullish on Shell and has a target price of £36 ($45.60) on the stock, giving it around 40% upside potential. They are currently trading around a three-times discount to their five-year average, Barclays' analysts said. Barclays has a target price of 160 euros ($169.50) on the Amsterdam-listed stock, giving it 44% potential upside.

Persons: BeSi, — CNBC's Michael Bloom Organizations: Barclays, Shell Barclays, Shell, London Stock Exchange, AstraZeneca, London, Stockholm Stock Exchanges, BE Semiconductor, BE Semiconductor Industries, Euronext Locations: U.S, —, Euronext Amsterdam, Amsterdam

☆ Cramer's Lighting Round: 'I'm not going to recommend' Altria
▼ + stars: | 2024-11-14 | by ( Julie Coleman | ) www.cnbc.com time to read: +1 min

Stock Chart Icon Stock chart icon Altria's year-to-date stock performance. Stock Chart Icon Stock chart icon Boeing's year-to-date stock performance. Stock Chart Icon Stock chart icon Becton Dickinson's year-to-date stock performance. Stock Chart Icon Stock chart icon IDEAYA Biosciences' year-to-date stock performance. Stock Chart Icon Stock chart icon AstraZeneca's year-to-date stock performance.

Persons: I'm, Becton, Becton Dickinson, Robert F, Kennedy Jr Organizations: Boeing, HHS, Biosciences, IDEAYA Biosciences, AstraZeneca

☆ European markets head for a lower open as traders await inflation data
▼ + stars: | 2024-11-12 | by ( Holly Ellyatt | ) www.cnbc.com time to read: +1 min

European markets are heading for a lower open Tuesday, as investors assess what U.S. President-elect Donald Trump's return to the White House could mean for the region's economy amid worries about possible tariffs. The U.K.'s FTSE 100 index is expected to open 18 points lower at 8,054, Germany's DAX down 93 points at 19,355, France's CAC down 34 points at 7,392 and Italy's FTSE MIB down 157 points at 33,659, according to data from IG. Investors will scrutinize a fresh batch of economic data this week, including an inflation reading from Germany on Tuesday, and U.S. inflation and U.K. gross domestic product on Thursday. Infineon, Bayer, Vodafone and AstraZeneca will report earnings, while U.K. unemployment and European and German ZEW economic sentiment figures are also due today. Asia-Pacific markets mostly fell overnight with investors exercising caution even as US.

Persons: Donald Trump's, Germany's DAX Organizations: France's CAC, IG, Infineon, Bayer, Vodafone, AstraZeneca Locations: Germany, Asia, Pacific

☆ Megacap tech stocks make some room — here is where investors are branching out
▼ + stars: | 2024-11-11 | by ( Jeff Marks | ) www.cnbc.com time to read: +4 min

With the S & P 500 trading around record highs and hanging around 6,000, one Wall Street firm revised its year-end S & P 500 price target, expecting more gains before the end of the year. We use the S & P 500 Short Range Oscillator as our guide to when the market is overbought or oversold. As a subscriber to the CNBC Investing Club with Jim Cramer, you will receive a trade alert before Jim makes a trade. THE ABOVE INVESTING CLUB INFORMATION IS SUBJECT TO OUR TERMS AND CONDITIONS AND PRIVACY POLICY , TOGETHER WITH OUR DISCLAIMER . NO FIDUCIARY OBLIGATION OR DUTY EXISTS, OR IS CREATED, BY VIRTUE OF YOUR RECEIPT OF ANY INFORMATION PROVIDED IN CONNECTION WITH THE INVESTING CLUB.

Persons: Jim Cramer, Dow, Donald Trump administration's, Morgan Stanley, Wells Fargo, Eaton, Trump's, Oppenheimer, Wells, Tyson, Jim Cramer's, Jim Organizations: CNBC, Nasdaq, Apple, Nvidia, Microsoft, Honeywell, BlackRock, Tyson Foods, AstraZeneca, Club, Disney, Jim Cramer's Charitable Locations: Dover, Wells Fargo

☆ The 2 things that will drive the stock market after last week's Trump-Fed rally
▼ + stars: | 2024-11-10 | by ( Zev Fima | ) www.cnbc.com time to read: +9 min

Stock Chart Icon Stock chart icon Performance since Nov. 1 closeThe stock market reaction Wednesday to Republican Donald Trump's victory over Democrat Kamala Harris was swift and powerful, sending the Dow , the S&P 500 and the Nasdaq to all-time highs. For the week, consumer discretionary, energy, industrials, financials, and information technology were the top five sectors. Only time will tell how the balance of power will play out and whether it's good or bad for the stock market. Barring anything catastrophic, President Joe Biden and Vice President Harris will hand Trump the baton of a healthy economy with moderating inflation and a strong stock market. Stock Chart Icon Stock chart icon Disney YTDDisney reports before the bell Thursday, and its experiences business will be in focus as it has softened recently due to the recent hurricane activity that forced closures at Florida theme park locations and inflation-weary consumers.

Persons: Donald Trump, Jerome Powell, Drew Angerer, Republican Donald Trump's, Kamala Harris, Dow, Jim Cramer, Wells Fargo Morgan Stanley, Trump, Joe Biden, Harris, FactSet, Helene, Milton, we're, Disney's, Tyson, JD.com Organizations: Federal, White House, Republican, Dow, Nasdaq, Staples, Honeywell, White, Capitol, Republicans, NBC News, Trump, Depot, Disney, CPI, PPI, Home Depot, Summer, IAC, Hertz, Tyson Foods, TSN, AstraZeneca, Occidental Petroleum, Rocket Companies, Cisco, Parts Locations: Washington ,, financials, Washington, inflect, Florida, Paris

☆ Here's why Eli Lilly bounced back, plus mega-caps lag while staples stocks rise
▼ + stars: | 2024-11-08 | by ( Jeff Marks | ) www.cnbc.com time to read: +5 min

Eli Lilly: Shares of Eli Lilly are finally putting together back-to-back sessions of gains. Eli Lilly shares traded at $903 before the quarterly report, putting the post-earnings pullback at about 7%. THE ABOVE INVESTING CLUB INFORMATION IS SUBJECT TO OUR TERMS AND CONDITIONS AND PRIVACY POLICY , TOGETHER WITH OUR DISCLAIMER . NO FIDUCIARY OBLIGATION OR DUTY EXISTS, OR IS CREATED, BY VIRTUE OF YOUR RECEIPT OF ANY INFORMATION PROVIDED IN CONNECTION WITH THE INVESTING CLUB. An Eli Lilly & Co. Zepbound injection pen arranged in the Brooklyn borough of New York, US, on Thursday, March 28, 2024.

Persons: Jim Cramer, Donald Trump's, aren't, Eli Lilly, Lilly, David Ricks, Wells, We've, Eli Lilly's, Tyson, Jim Cramer's, Jim, Shelby Knowles Organizations: CNBC, ., Treasury, Companies, Tech, Tesla, Arista Networks, Costco, United States, Disney, Tyson Foods, AstraZeneca, Spotify, Occidental, Cisco, Advance, Materials, Jim Cramer's Charitable, Bloomberg, Getty Locations: China, Wells Fargo, Brooklyn, New York

☆ AstraZeneca shares fall on report of potential China probe fallout
▼ + stars: | 2024-11-05 | by ( ) www.cnbc.com time to read: +2 min

The Astrazeneca logo is pictured at the World Artificial Intelligence Conference 2021 in Shanghai, China, July 7, 2021. "As a matter of policy, we do not comment on speculative media reports including those related to ongoing investigations in China," AstraZeneca said. "If requested, we will fully cooperate with the Chinese authorities," the company added and said that its operations and delivery of medicines were ongoing in China. AstraZeneca is one of the biggest multinational drugmakers in China, which accounts for 13% of its overall revenue. In 2022, Chinese authorities had summoned AstraZeneca officials over an investigation of suspected medical insurance fraud by its employees, and had ordered that the drugmaker tighten its marketing activities.

Persons: Leon Wang, Wang, AstraZeneca Organizations: Astrazeneca, Artificial Intelligence, AstraZeneca, country's pharma Locations: Shanghai, China, Swedish

☆ Daiichi Sankyo COO: Partnerships with Merck & AstraZeneca going very well
▼ + stars: | 2024-11-01 | by ( ) www.cnbc.com time to read: 1 min

In this videoShare Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailDaiichi Sankyo COO: Partnerships with Merck & AstraZeneca going very wellDaiichi Sankyo's chief operating officer, Hiroyuki Okuzawa speaks about the company's drug pipeline and alliances with global pharmaceutical firms.

Persons: Hiroyuki Okuzawa Organizations: Merck, AstraZeneca

☆ AstraZeneca says its China operations president under investigation
▼ + stars: | 2024-10-30 | by ( ) www.cnbc.com time to read: +1 min

The office building of biopharmaceutical company AstraZeneca is being seen in Shanghai, China, on May 23, 2024. AstraZeneca 's China president is under investigation and is cooperating with Chinese authorities, the company said on Wednesday, sending shares down as much as 5.3%. When asked about Wang's whereabouts, a company spokesperson only reiterated that the executive was under investigation. In a statement, the drugmaker said its Chinese operations were "under the leadership of the current general manager of AstraZeneca China," without providing further details. AstraZeneca shares were down 5.2% at 1352 GMT.

Persons: Leon Wang Organizations: AstraZeneca Locations: Shanghai, China, drugmakers, United States, AstraZeneca China

☆ Merck says experimental RSV treatment protected infants in trial, paving way for potential approval
▼ + stars: | 2024-10-17 | by ( Annika Kim Constantino | ) www.cnbc.com time to read: +3 min

Merck plans to discuss the study data with regulators worldwide, with a goal of making the treatment available for infants as early as the 2025 to 2026 RSV season, according to a release. The trial examined the safety and efficacy of a single dose of the treatment, clesrovimab, in healthy preterm and full-term infants entering their first RSV season. Results were consistent through both the five-month and six-month time points in the trial, Merck said. Merck's clesrovimab could potentially compete against a similar treatment from Sanofi and AstraZeneca called Beyfortus, which was in short supply nationwide last RSV season due to unprecedented demand. But Merck's treatment can be administered to infants regardless of their weight, which the company said may offer convenience in terms of dosing.

Persons: Merck, Clesrovimab, Dr, Octavio Ramilo, Ramilo, Merck's Organizations: Merck, New York Stock Exchange, Infectious, Research, Sanofi, AstraZeneca, Pfizer, GSK Locations: Los Angeles, St

Valued at $4 billion in 2021, Cerebras is reportedly seeking to roughly double that in its IPO. The customer, G42, is backed by Microsoft , and it's entirely responsible for the $1.43 billion purchase commitment. G42 can pick up $500 million more in Cerebras shares if it commits to spend $5 billion on the company's computing clusters. The major Wall Street banks, for their part, are finding other ways to play in the burgeoning AI infrastructure market. Fitch, who said he sold out of his Nvidia stock years ago, told CNBC that the benefits outweigh the risks.

Persons: Andrew Feldman, Ramsey Cardy, Cerebras, —, David Golden, it's, prepayment, CFIUS, Mike Gallagher, Gina Raimondo, Goldman Sachs, Morgan Stanley, JPMorgan Chase, Young, There's, Peter Thiel, Eva Marie Uzcategui, there's, Thiel, Jim Fitch, Fitch, Feldman Organizations: Cerebras Systems, Nvidia, Revolution Ventures, JPMorgan Chase, Microsoft, AstraZeneca, GlaxoSmithKline, Mayo Clinic, Treasury, Foreign Investment, Reuters, Chinese Communist Party, JPMorgan, Citigroup, Barclays, BDO, KPMG, Deloitte, Ernst, Riverstone Networks, CoreWeave, Clarium Capital Management LLC, Bloomberg, Getty, Mizuho Securities, Venture, CNBC, Devices Locations: Toronto, U.S, Sunnyvale , California, Abu Dhabi, China, Miami , Florida, Los Angeles, Florida

☆ Beyond Novo: Fund manager likes this under-the-radar pharma stock with a weight loss drug in the works
▼ + stars: | 2024-10-04 | by ( Amala Balakrishner | In Amala-Balakrishner | ) www.cnbc.com time to read: +3 min

"Maybe that weight loss product (by United Laboratories) works, maybe it doesn't. United Laboratories' price-to-earnings of 5.8 times is a fraction of the 34.3 times that Novo Nordisk is trading at, Peche added. [United Laboratories] is making smooth progress in R & D and targets to launch Liraglutide in 2024. Their comments follow United Laboratories' "faster than expected earnings" growth in the first half of the year. Analysts' average price target on United Laboratories is 12.95 Hong Kong dollars, giving it 28.2% potential upside.

Persons: Sean Peche, it's, Peche, there's, that's, Eli Lilly, Amgen, Carol Dou, Sunny Chen, UOB Kay Hian, bode Organizations: Novo Nordisk, Ranmore Fund Management, United Laboratories, Pfizer, AstraZeneca, Global Equity Fund, Hong, Hong Kong bourse, HK Locations: Hong Kong, Novo, Europe, U.S

☆ Trump leads, and his party follows, on vaccine skepticism
▼ + stars: | 2024-09-30 | by ( Darius Tahir | Kff Health News | ) edition.cnn.com time to read: +10 min

Campaign spokespeople have previously said that pledge would apply only to schools with covid mandates. And skepticism about covid vaccines is blossoming into suspicion of vaccines generally among that group, he said. “It follows from this rebellion against the covid vaccine mandates.”Vaccine opposition has divided the GOP. “You suffered the consequences.”Onder “has never done covid vaccine research” and opposes covid vaccine mandates, his campaign manager, Charley Lovett, told KFF Health News. It also calls for enshrining a patient’s ability to opt out of vaccine mandates in the state’s Bill of Rights.

Persons: Donald Trump’s, what’s, Republicans don’t, ” Trump, Trump, Matt Motta, —, Robert F, Kennedy Jr, Tucker Carlson, Kennedy, “, Judith Winston, Obama, ” Winston, Tom Frieden, ”, Robert Blendon, Ron DeSantis, Bob Onder, ” Onder “, Charley Lovett, Lovett, Onder “, Onder, Wise, Bill Gates, ” Wise, Roger Severino, Severino, Lawrence Gostin, Dr, Sanjay Gupta, Kevin Roberts, JD Vance —, Roberts Organizations: Health, Republican, Trump, Republicans, KFF Health, Politico, Boston University, Texas GOP, Fox News, NIH, CDC, Department of Education, Centers for Disease Control, ”, World Health Organization, Republican Party, GOP, Florida Gov, Congress, AstraZeneca, Facebook, Texans, Vaccine, Rights, Department of Health, Human Services ’, Civil Rights, Heritage Foundation, Georgetown University, Get CNN, CNN Health, Heritage, KFF Locations: statehouses, Texas, New Jersey, Oregon, U.S, Wyoming, Missouri

Prices for prescription pharmaceutical drugs have skyrocketed, disproportionately making them harder for people of color to afford, a new report finds. Black people in the U.S. are more likely to be diagnosed with the condition and die from it, the report highlights. Several health care advocacy organizations, including Patients for Affordable Drugs and Health Care for America Now, are pushing for policies that will help lower the financial burden of patients. Both organizations supported the Inflation Reduction Act, a law signed by President Joe Biden that aims to reduce prescription drug prices. In the meantime, Basey, of Patients for Affordable Drugs, said her organization continues to push for bills like S.142, which prevents pharmaceutical companies from paying generic brands to delay the release of their drugs on the market.

Persons: Merith, “, ” Basey, ”, Basey, haven’t, Carrol Olinger, Olinger, ” Olinger, Joe Biden, Margarida Jorge, Jorge, hasn’t, “ It’s, ” Jorge, she’s Organizations: Drugs, New England, of Medicine, AstraZeneca, NBC News, Bristol Myers Squibb, ” Pharmaceutical, U.S, Health Care, America, Centers for Disease Control, Biden Locations: U.S, Daiichi, Hope Mills , North Carolina, Basey

☆ Drugmakers bet billions that targeted radiation could become the next cancer breakthrough
▼ + stars: | 2024-09-16 | by ( Angelica Peebles | In Angelicapeebles | ) www.cnbc.com time to read: +9 min

watch nowDrugmakers are betting that delivering radiation directly to tumors will become the next big cancer breakthrough. That can allow the treatment to deliver radiation to cancer cells and spare the rest of the body from the level of damage that comes with many cancer drugs. For Pluvicto, patients come in once every six weeks for up to six treatments. One opportunity Bristol Myers Squibb sees is combining radiopharmaceuticals with existing cancer drugs like immunotherapy, said Robert Plenge, Bristol's chief research officer. But she thinks the technology will become an important part of cancer drugs in the next decade.

Persons: Eli Lilly, They've, Michael Schmidt, Schmidt, Franco Origlia, Jacob Van Naarden, Eli Lilly's, Lilly, Biopharma, Van Naarden, Radiopharmaceuticals, Bristol Myers, Ben Hickey, RayzeBio, Hickey, Victor Bulto, Bulto, Timothy Korytko, Ronald Coy, Sharon, Ronald Coy Ronald Coy, Coy, who's, Coy hasn't, she's, we've, Eli Lilly's Van Naarden, Bristol Myers Squibb, Robert Plenge, Susan Galbraith, Galbraith Organizations: Bristol Myers Squibb, AstraZeneca, Guggenheim Securities, Novartis, NSA, Pharmaceutical, Bassett Healthcare Network, Bristol, Fusion Pharmaceuticals, Guggenheim Locations: Aedea Rome, Italy, radiopharmaceuticals, Swiss, FactSet, Bristol, Indiana, U.S, New York, Bassett

☆ Stocks making the biggest moves premarket: Boeing, Oracle, Moderna and more
▼ + stars: | 2024-09-13 | by ( Samantha Subin | ) www.cnbc.com time to read: +1 min

Boeing — The stock sank 4% after Boeing factory workers went on strike early Friday after rejecting a new labor contract. Oracle — Shares of the database software company rallied more than 6%. Oracle lifted its fiscal 2026 revenue forecast and shared strong guidance for the 2029 fiscal year. RH — Shares of the home furnishings retailer surged 21% after a stronger-than-expected second quarter. Adobe — Shares sank more than 8% after the company issued softer-than-expected guidance for the current quarter.

Persons: Max, Kevin Clark, — CNBC's Michelle Fox, Lisa Han, Sarah Min, Jesse Pound Organizations: Boeing, Oracle —, Oracle, Moderna —, JPMorgan, —, Adobe —, Adobe, Aptiv, U.S . Securities, Exchange Commission, AstraZeneca —, Deutsche Bank

☆ Here are Friday's biggest analyst calls: Nvidia, Netflix, Tesla, Kroger, Arm, Oracle, Eli Lilly, PNC, GE Vernova & more
▼ + stars: | 2024-09-13 | by ( Michael Bloom | ) www.cnbc.com time to read: +6 min

Here are Friday's biggest calls on Wall Street: Raymond James initiates Arm as outperform Raymond James said the semis company is well positioned for AI. Citi downgrades Capri Holdings to neutral from buy Citi said the risk/reward is more balanced for the owner of brands like Michael Kors. UBS reiterates Oracle as buy UBS raised its price target on the stock to $200 per share from $175. The feedback on Oracle's top-line growth was overall positive..." UBS reiterates PNC as buy UBS said the bank is a high conviction idea. " Citi resumes Eli Lilly as buy Citi resumed coverage of the stock and says it's well positioned.

Persons: Raymond James, Jefferies, SLG, CFRA, it's, datopotamab, Michael Kors, haven't, Morgan Stanley, EQT, Citi, Eli Lilly, Lilly, Tesla, BEV, Wells Organizations: Arm Holdings, ARM, Citi, Green, Kroger, Macquarie, Rio Tinto, Deutsche Bank, AstraZeneca, Deutsche, Capri Holdings, Barclays, Garmin, GM, BMO, GE, UBS, Oracle, Oracle's, PNC, JPMorgan, Netflix, JPMorgan downgrades Moderna, Nvidia, NVIDIA Locations: GenAI, New York, Rio, RIO, Las Vegas

☆ The current market is 'directionless,' one CIO says, naming 6 stocks he likes right now
▼ + stars: | 2024-09-12 | by ( Amala Balakrishner | In Amala-Balakrishner | ) www.cnbc.com time to read: +4 min

Defensive and dividend plays Alexander's strategy in playing the market right now is through defensive sectors and dividend players. As for dividend plays, Alexander is bullish on the utilities and telco sectors amid falling Treasury yields . Big pharma plays Alexander is also likes health-care and biotech players, especially big pharmaceutical companies producing products serving medical needs. Names he likes include AbbVie , AstraZeneca , Novartis and Johnson & Johnson . Johnson & Johnson, meanwhile, has been building out a "pipeline of drugs," Alexander added.

Persons: Ted Alexander, we've, we're, Alexander, it's, bullish, Durex, They've, Mead Johnson, Johnson Organizations: U.S, U.S . Federal, Sydney, Telecommunications, AT, Verizon, Frontier Communications, London Stock Exchange, Big pharma, AstraZeneca, Novartis, Johnson Locations: U.S ., South Dallas, U.S

☆ A promising cancer treatment is poised for explosive growth, says Redburn Atlantic. These stocks are on its buy list
▼ + stars: | 2024-09-12 | by ( Michelle Fox | ) www.cnbc.com time to read: +5 min

The latest weapon in the battle against cancer is showing promising results — and it's a growing opportunity for investors, according to Redburn Atlantic. To treat cancer, targeted radiopharmaceutical therapy directly goes after tumors with radiation by binding a radioactive particle to a targeting molecule. Delving into diagnostics There are also opportunities in the radiopharma diagnostics space, according to Redburn Atlantic. It has a "strong pipeline of radionuclides for both diagnosis and therapy," he said. "Lantheus benefits from its focus on this rapidly expanding market, with 78% of revenues from radiopharmaceuticals and related products," Ridley-Day added.

Persons: Ed Ridley, Eli Lilly, Myers, Ridley, Astra's, Lantheus Organizations: Big pharma, Novartis, Mariana Oncology, Biopharma, Myers Squibb, RayzeBio, AstraZeneca, Fusion Pharmaceuticals, GE Healthcare Technologies, Lantheus Holdings, GE Healthcare, GE Locations: Bristol, radiopharmaceuticals

☆ AstraZeneca shares fall 5% on disappointing lung cancer drug trial results
▼ + stars: | 2024-09-10 | by ( Karen Gilchrist | ) www.cnbc.com time to read: +1 min

An illustrative image of a person holding a medical syringe and a Covid-19 vaccine vial in front of the the AstraZeneca logo displayed on a screen. On Wednesday, January 12, 2021, in Edmonton, Alberta, Canada. (Photo by Artur Widak/NurPhoto via Getty Images)AstraZeneca shares fell more than 5% Tuesday morning, the biggest one-day drop in seven months, after the British pharmaceutical giant announced disappointing lung cancer drug trial results. The Covid-19 vaccine maker was trading at the bottom of the FTSE 100 and dragged the wider healthcare sector lower after data published Monday showed that its experimental drug did not significantly improve overall survival results for patients. The late-stage trial results from the TROPION-Lung01 Phase III trial showed that the overall survival rate from the new drug "did not reach statistical significance," the company said.

Persons: Artur Widak Organizations: AstraZeneca, Getty Images Locations: Edmonton , Alberta, Canada, London

City of London skyline on 10th June 2024 in London, United Kingdom. The City of London is a city, ceremonial county and local government district that contains the primary central business district CBD of London. Mike Kemp | In Pictures | Getty ImagesLONDON — European stocks were mixed on Tuesday, following a more positive session at the start of the week. The more mixed picture for European stocks today comes after regional markets closed higher on Monday, shrugging off last week's negative sentiment. Investors are largely looking ahead to next week's meeting of the U.S. Federal Reserve where an interest rate cut is widely anticipated.

Persons: Mike Kemp, Germany's DAX, shrugging Organizations: CAC, Tech, AstraZeneca, Nasdaq, Investors, U.S . Federal Reserve Locations: London, United Kingdom, The City, Asia, Pacific

The first round of Medicare drug price negotiations has come to an end – but we still don't know the final prices that the U.S. government and pharmaceutical companies have agreed on. They all maintain that Medicare drug price negotiations are a long-term threat to the pharmaceutical industry's drug innovation and profits, but the immediate dust has somewhat settled. That's based on executive commentary during the recent quarterly earnings calls of Bristol Myers Squibb and Johnson & Johnson , among other companies. Novartis CEO Vasant Narasimhan said on July 18 that the short-term impact from Medicare drug price negotiations "might be manageable on our first set of drugs." Executives at each of the drugmakers similarly emphasized their opposition to Medicare drug price negotiations on their respective earnings calls.

Persons: Joe Biden, Johnson, Joe Biden's, Christopher Boerner, Bristol Myers, Robert Michael, We've, Michael, Jennifer Taubert, Vasant Narasimhan, Narasimhan, Bristol Myers Squibb's Boerner, Boehringer Ingelheim, Annika Organizations: National Institutes of Health, Medicare, Bristol Myers Squibb, Johnson, Pfizer, J, Novartis, Merck, Novo Nordisk, AstraZeneca Locations: Bethesda , Maryland, U.S, annikakim.constantino@nbcuni.com

☆ Bristol Myers surges 10%, its biggest increase since 2008, after boosting profit forecast
▼ + stars: | 2024-07-26 | by ( Kelly Cloonan | ) www.businessinsider.com time to read: +3 min

Bristol Myers boosted its adjusted earnings for the year to between 60 and 90 cents a share, up 20 cents from its last forecast. AdvertisementOf Bristol Myers' existing drugs, Eliquis saw a 7% increase in sales year-over-year. Cancer drug Opdivo and blood cancer treatment Revlimid also saw promising results and beat quarterly sales estimates. The company reiterated its plan to cut $1.5 billion in costs by 2025, which was announced at its last quarterly earnings call. Bristol Myers is only the latest of a host of other drugmakers to raise their earnings guidance this week.

Persons: Myers, —, Bristol Myers, Christopher Boerner, Eliquis, Revlimid, David Elkins, Boerner, AbbVie Organizations: Bristol, Myers Squibb, Service, Cancer, FDA, AstraZeneca, Roche, Sanofi Locations: Bristol

☆ AstraZeneca CEO on revenue beat
▼ + stars: | 2024-07-25 | by ( Angelica Peebles | ) www.cnbc.com time to read: 1 min

Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailAstraZeneca CEO on revenue beatAstraZeneca CEO Pascal Soriot joins 'Squawk on the Street' to discuss the company's quarterly earnings results, its goal to double sales by 2030, and its Farxiga drug.

Persons: Pascal Soriot Organizations: AstraZeneca

☆ Alphabet earnings and 3 more things we're watching in the stock market next week
▼ + stars: | 2024-07-20 | by ( Zev Fima | ) www.cnbc.com time to read: +12 min

But in general, this is the kind of development we've hoped to see ever since Starbucks' massive earnings miss April 30. We'll take the nearly 7% pop in shares Friday and hope it's only the beginning of recovery for the beaten-up stock. Fed's fave inflation measure : The personal spending and income report will be the most closely watched economic report next week. Earnings : As the second-quarter earnings season picks up pace, we'll hear from five Club holdings next week including Google parent Alphabet . Jim waits 45 minutes after sending a trade alert before buying or selling a stock in his charitable trust's portfolio.

Persons: Russell, Donald Trump, — Trump, Jim Cramer, Trump, Donald Trump's, Taiwan's TSMC, Joe Biden's, Biden, Biden's, he's, Elliott, we've, We'll, it's, we'll, Sartorius, Ford, Jim Farley, We're, Honeywell management's, —, Zions, BOK, Brown, BRO, Lockheed Martin, Philip Morris, Clark, Lamb, Edwards Lifesciences, DOV, Dr Pepper, CARR, Baker Hughes, Booz Allen Hamilton, Jim Cramer's, Jim Organizations: Federal Reserve, Nasdaq, Dow, Republican National Convention, GOP, Bloomberg Businessweek, Trump, Elliott Management, Starbucks, Street Journal, Technology, General Motors, Honeywell, Dover, Products Company, Verizon, Truist, SAP, Semiconductors, Crown Holdings, Cadence Design Systems, Medpace Holdings, AGNC Investment, Logitech International S.A, KKR Real Estate Finance Trust, Berkley Corp, Spotify Technology S.A, United Parcel Service, GE Aerospace, GE, Cola Company, Lockheed, Comcast, Polaris Industries, Philip Morris International, Company, HCA Healthcare, Moody's Corporation, Enphase Energy, Texas Instruments Incorporated, Chubb Corporation, Seagate Technology plc, Maine, Packaging Corporation of America, Weatherford International plc, Canadian National Railway Company, FTAI Aviation Ltd, Mattel, Vertiv Holdings Co, Lamb Weston Holdings, NextEra Energy, Tenet Healthcare, Fisher, GE Vernova, Boston Scientific Corporation, General Dynamics, Lennox International, Software Technologies, CME Group, Fortive Corporation, Co, Roper Technologies, Teck Resources Limited, Blackstone Mortgage Trust, Economico Mexicano S.A, Dominion Freight, Otis Worldwide Corporation, OTIS, Ford Motor Company, Grill, Business Machines, IBM, Viking Therapeutics, Las Vegas Sands Corp, Newmont, Whirlpool, Globe, WM, O'Reilly Automotive, Annaly Capital Management, Honeywell International, American Airlines Group, Hasbro, Southwest Airlines Co, New York Community Bancorp, RTX Corporation, AstraZeneca, Carrier Global Corporation, Integer Holdings Corporation, Valero Energy, Texas, Juniper Networks, Boston Beer Company, Physicians Realty Trust, Allison Transmission Holdings, Corp, Columbia Banking, Digital Realty Trust, Edison International, Myers Squibb, Charter Communications, 3M Company, Booz, Centene Corporation, AON, Barnes, Colgate, Palmolive, Jim Cramer's Charitable, CNBC, U.S Locations: U.S, Taiwan, FactSet, China, Dover, Cleveland, Alexandria, ZION, W.R, Freeport, Kimberly, Cal, Teck, Las, ORLY, New, Banc, Bristol, Milwaukee , Wisconsin

Search resuls for: "AstraZeneca"

25 mentions found